Masitinib Shows Promise in Study For Treating Progressive MS Patients
Masitinib Shows Promise in Study For Treating Progressive MS Patients JULY 24, 2015 Progressive multiple sclerosis patients treated with AB…
PROGRESSIVE MS – a Sharper Focus
Progressive multiple sclerosis is a form of multiple sclerosis that is characterized as having nerve degeneration (the breakdown…
Stuart Schlossman
MediciNova Announces Update On Phase 2b Trial of MN-166 (Ibudilast) Involving 255 Progressive MS Patients
MediciNova, Inc., a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet…
Stuart Schlossman
How do we slow down progression, for Progressive MS Patients?
Published June 1, 2015 Ashley Ringstaff, of MS World, asks Dr. Jack Burks, how we can slow progression for those…
Stuart Schlossman
Highlights from the American Academy of Neurology’s 2015 Annual Meeting – includes PPMS updates
The American Academy of Neurology’s (AAN’s) 67th Annual Meeting took place in Washington, DC April 18th-25th. The AAN is an…
Stuart Schlossman
MS News in Australia: New SPMS Trial underway
The MIS416 trial is a clinical research trial1 now enrolling patients with Secondary Progressive Multiple Sclerosis (SPMS) in Australia. Full information about…
Stuart Schlossman
Progressive MS: Looking for answers NOW
Impressive reading for thousands seeking answers By Douglas Landsman Apr 28, 2015 People who live with progressive MS have many questions, but…
Stuart Schlossman
Firm Claims Biotin Drug Improves Function in Progressive MS
One-year study meets primary disability-based endpoint, company says To read, CLICK: http://www.medpagetoday.com/MeetingCoverage/AAN/51048 ~~~~~~~~~~~~~~~~~~~~ Keep CURRENT with MS Views and News – OPT-IN…
Stuart Schlossman
MedDay provides update on pioneering pivotal Phase III study design in Progressive Multiple Sclerosis
~ Phase III data to be disclosed at AAN Annual Meeting in Clinical Trials Plenary Session on April 24th 2015…
Stuart Schlossman
Seeking Answers for Progressive MS
An invitational meeting in Boston marks a step forward in a concerted international push to find effective therapies to target…
Stuart Schlossman
